Ultomiris Drug Market 2025: Advancing Rare Disease Treatment...

σε πρόσθεσε στο άλλο

2026-07-06 08:03:54 -

Ultomiris Drug Market 2025: Advancing Rare Disease Treatment Through Long-Acting Complement Inhibition

Ultomiris Drug Market 2025: Advancing Rare Disease Treatment Through Long-Acting Complement Inhibition The global Ultomiris Drug Market is witnessing robust growth, driven by the increasing prevalence of rare complement-mediated diseases, expanding regulatory approvals, and growing adoption of long-acting biologic therapies. The market is projected to grow from USD 5.2 billion in...

0 Σχόλια 0 Μοιράστηκε 3 Views 0 Προεπισκόπηση